Patients with | No. of cases (%) |
---|---|
Treatment failure assessed at 72Â hours after onset of illness | 225 /991 (22.7) |
30-day mortality | 262 /1,024 (25.6) |
Clinical outcomes assessed at 12-week after onset of illness | Total No. = 860 |
  Recurrence | 27 (3.1) |
  Complications | 153 (17.8) |
  Metastatic infections (site of metastasis)a | 138 (16.0) |
   Heartb | 20 (2.3) |
   Lung | 84 (9.8) |
   Bonec | 8 (0.9) |
   Fundusd | 6 (0.7) |
   Skin | 18 (2.1) |
   Otherse | 20 (2.3) |
  Survival without recurrence or complications | 455 (52.9) |
  12-week mortality | 314 (36.5) |